Onychomycosis Treatment Market - Forecast(2021 - 2026)

Report Code: HCR 0328 Report Format: PDF + Excel (Delivery in 48 Hrs)

Onychomycosis Treatment Market Overview

Onychomycosis Treatment Market size is estimated to reach $3.8 billion by 2026, growing at a CAGR of 5.5% during the forecast period 2021-2026. Onychomycosis is a fungal infection of the fingernails and toenails and is the most common nail infection in patients with athlete’s foot and genetic predisposition. The prevalence of onychomycosis is increasing with the growing incidences of diseases, such as peripheral vascular diseases, diabetes mellitus, and psoriasis. The rise in the adoption of laser technologies for the treatment of Distal Subungual Onychomycosis (DSO) in hospitals, growing awareness about onychomycosis therapeutics among dermatologists and podiatrists, increase in the adoption of drug therapies, and growing investment by the key players to develop high-quality therapies for the treatment of onychomycosis are the factors that are set to drive the growth of the Onychomycosis Treatment Market for the period 2021-2026. 

Onychomycosis Treatment Market Report Coverage

The report: “Onychomycosis Treatment Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Onychomycosis Treatment Market. 
By Disease Type: Distal Subungual Onychomycosis (DSO), Proximal Subungual Onychomycosis (PSO), White Superficial Onychomycosis (WSO), Candida Onychomycosis, and Others.
By Therapy Type: Laser Therapy, Photodynamic Therapy, and Drug Therapy.
By Distribution Channel: Hospitals and Clinics, Online Channels, Drug Stores, and Others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa).

Key Takeaways

  • Geographically, North America Onychomycosis Treatment Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing adoption of drugs as first-line therapy for the treatment of onychomycosis.
  • The increase in the adoption of laser technologies for the treatment of DSO in hospitals is driving the Distal Subungual Onychomycosis (DSO) segment. However, the rise in the side effects associated with the treatment of onychomycosis is one of the major factors that is said to reduce the growth of the Onychomycosis Treatment Market.
  • Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Onychomycosis Treatment Market report.
Onychomycosis Treatment Market Size, By Disease Type, 2020-2026 (USD Million)

For More Details on This Report - Request for Sample

Onychomycosis Treatment Market Segment Analysis-By Disease Type

The Onychomycosis Treatment Market based on the Disease Type can be further segmented into Distal Subungual Onychomycosis (DSO), Proximal Subungual Onychomycosis (PSO), White Superficial Onychomycosis (WSO), Candida Onychomycosis, and Others. The Distal Subungual Onychomycosis (DSO) segment held the largest share in 2020 and is also estimated to be the fastest-growing segment with a CAGR of 6.2% over the period 2021-2026. This growth is owing to the factors such as the increase in the adoption of laser technologies for the treatment of DSO in hospitals and growing awareness about the availability of various therapies for DSO among patients. The rise in the research and development activities to develop advanced products for the treatment of DSO nail infection is driving the growth of the Onychomycosis Treatment Market. The White Superficial Onychomycosis (WSO) segment held the second-largest share in 2020 owing to the factors such as the growing adoption of antifungal agents for the treatment of WSO and the rise in the prevalence of WSO in developed nations.

Onychomycosis Treatment Market Segment Analysis-By Therapy Type

The Onychomycosis Treatment Market based on the Therapy Type can be further segmented into Laser Therapy, Photodynamic Therapy, and Drug Therapy. The Drug Therapy segment held the largest share in 2020 owing to the factors such as the growing adoption of drugs as first-line therapy for the treatment of fungal infections in the nails and the rise in product launches. The rise in the investment by the key players to develop high-quality drugs for the treatment of fungal infections in the nails is driving the growth of the Onychomycosis Treatment Market. The Laser Therapy segment is estimated to be the fastest-growing segment with a CAGR of 6.4% over the period 2021-2026. This growth is owing to the factors such as the rise in the demand for laser therapy for the treatment of DSO in hospitals and the growing resistance to oral and topical antifungal agents.

Onychomycosis Treatment Market Segment Analysis-By Geography

The Onychomycosis Treatment Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and Rest of World. North America held the largest share with 27% of the overall market in 2020. The growth in this segment is owing to the factors such as the growing awareness about onychomycosis therapeutics among dermatologists and podiatrists and an increase in product launches by key players. The rise in the adoption of drugs as first-line therapy for the treatment of onychomycosis is driving the growth of the Onychomycosis Treatment Market. Asia-Pacific segment is estimated to be the fastest-growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as the rise in the adoption of antifungal agents for the treatment of WSO and the growing investment by the key players to develop high-quality therapies for the treatment of onychomycosis.

Onychomycosis Treatment Market Drivers

Rise in the Adoption of Drug Therapies

Drug therapies are increasingly being adopted as first-line therapy for the treatment of fungal infections in the nails owing to the growing availability of drugs, such as itraconazole, griseofulvin, terbinafine, and ketoconazole. The key players are also increasing their investment to develop high-quality drugs for the treatment of fungal infections in the nails, which is one of the major factors driving the growth of the Onychomycosis Treatment Market.

Increase in Awareness about Onychomycosis Therapeutics among Dermatologists and Podiatrists

The rise in awareness about onychomycosis therapeutics among dermatologists and podiatrists owing to the growing prevalence of onychomycosis across the world has propelled the demand for laser therapies and photodynamic therapies in hospitals. Governments of various nations are also focusing on creating awareness about the availability of various therapies for the treatment of onychomycosis, which is further propelling the growth of the Onychomycosis Treatment Market.

Onychomycosis Treatment Market Challenges

The Rise in the Side Effects Associated with the Treatment of Onychomycosis

The key players in the market are collaborating with other players to carry out various research and development activities for launching advanced drug therapies for the treatment of onychomycosis. However, the rise in the side effects associated with the treatment of onychomycosis is one of the major factors that is estimated to reduce the growth of the Onychomycosis Treatment Market.

Onychomycosis Treatment Market Competitive Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Onychomycosis Treatment Market. Key companies of this market are Novartis AG, Galderma, Mundipharma, Moberg Pharma, Cardinal Health, Inc, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, TheOTCLab, Bayer AG, and GlaxoSmithKline plc among others.

Partnerships/Product Launches:

  • In October 2020, Mundipharma has launched the latest addition to its BETADINE ™ range of infectious disease therapies. This BETADINE™ EMTRIX™ fungal nail solutions effectively treats the onychomycosis and improves the nail appearance after regular application.
  • In April 2020, TheOTCLab has launched the FungeX range for innovative nail fungus treatments. The product was a unique and patented application and provides eight hours of treatment while patients suffering from onychomycosis were asleep.
  • In February 2019, Moberg Pharma has entered into a partnership with Bayer for marketing and selling MOB-015 in Europe. MOB-015 is a topical treatment of onychomycosis and is an internally developed topical formulation based on its experience.

Relevant Links:

Report Code: CPR 0142

Report Code: CMR 52134

For more Lifesciences and Healthcare Market reports, please click here

1. Onychomycosis Treatment Market - Overview
    1.1 Definitions and Scope
2. Onychomycosis Treatment Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Disease Type
    2.3 Key trends by Distribution Channel
    2.4 Key trends by Geography
3. Onychomycosis Treatment Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies 
    3.5 Pricing Analysis
4. Onychomycosis Treatment Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Onychomycosis Treatment Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Onychomycosis Treatment Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Onychomycosis Treatment Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Onychomycosis Treatment Market – By Disease Type(Market Size –$Million/$Billion)
    8.1 Distal Subungual Onychomycosis (DSO)
    8.2 Proximal Subungual Onychomycosis (PSO)
    8.3 White Superficial Onychomycosis (WSO)
    8.4 Candida Onychomycosis
    8.5 Others
9. Onychomycosis Treatment Market – By Therapy Type(Market Size –$Million/$Billion)
    9.1 Laser Therapy
    9.2 Photodynamic Therapy
    9.3 Drug Therapy
10. Onychomycosis Treatment Market – By Distribution Channel(Market Size –$Million/$Billion)
    10.1 Hospitals and Clinics
    10.2 Online Channels
    10.3 Drug Stores
    10.4 Others
11. Onychomycosis Treatment Market - By Geography(Market Size –$Million/$Billion) 
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Onychomycosis Treatment Market - Entropy
13. Onychomycosis Treatment Market – Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Onychomycosis Treatment Market – Key Company List by Country Premium Premium
15. Onychomycosis Treatment Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables:

Table 1: Onychomycosis Treatment Market Overview 2021-2026
Table 2: Onychomycosis Treatment Market Leader Analysis 2018-2019 (US$)
Table 3: Onychomycosis Treatment Market Product Analysis 2018-2019 (US$)
Table 4: Onychomycosis Treatment Market End User Analysis 2018-2019 (US$)
Table 5: Onychomycosis Treatment Market Patent Analysis 2013-2018* (US$)
Table 6: Onychomycosis Treatment Market Financial Analysis 2018-2019 (US$)
Table 7: Onychomycosis Treatment Market Driver Analysis 2018-2019 (US$)
Table 8: Onychomycosis Treatment Market Challenges Analysis 2018-2019 (US$)
Table 9: Onychomycosis Treatment Market Constraint Analysis 2018-2019 (US$)
Table 10: Onychomycosis Treatment Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Onychomycosis Treatment Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Onychomycosis Treatment Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Onychomycosis Treatment Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Onychomycosis Treatment Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Onychomycosis Treatment Market Value Chain Analysis 2018-2019 (US$)
Table 16: Onychomycosis Treatment Market Pricing Analysis 2021-2026 (US$)
Table 17: Onychomycosis Treatment Market Opportunities Analysis 2021-2026 (US$)
Table 18: Onychomycosis Treatment Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Onychomycosis Treatment Market Supplier Analysis 2018-2019 (US$)
Table 20: Onychomycosis Treatment Market Distributor Analysis 2018-2019 (US$)
Table 21: Onychomycosis Treatment Market Trend Analysis 2018-2019 (US$)
Table 22: Onychomycosis Treatment Market Size 2018 (US$)
Table 23: Onychomycosis Treatment Market Forecast Analysis 2021-2026 (US$)
Table 24: Onychomycosis Treatment Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Top Companies 2018 (US$)Onychomycosis Treatment Market, Revenue & Volume
Table 26: Product Launch 2018-2019Onychomycosis Treatment Market, Revenue & Volume
Table 27: Mergers & Acquistions 2018-2019Onychomycosis Treatment Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Onychomycosis Treatment Market 2021-2026
Figure 2: Market Share Analysis for Onychomycosis Treatment Market 2018 (US$)
Figure 3: Product Comparison in Onychomycosis Treatment Market 2018-2019 (US$)
Figure 4: End User Profile for Onychomycosis Treatment Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Onychomycosis Treatment Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Onychomycosis Treatment Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Onychomycosis Treatment Market 2018-2019
Figure 8: Ecosystem Analysis in Onychomycosis Treatment Market 2018
Figure 9: Average Selling Price in Onychomycosis Treatment Market 2021-2026
Figure 10: Top Opportunites in Onychomycosis Treatment Market 2018-2019
Figure 11: Market Life Cycle Analysis in Onychomycosis Treatment Market
Figure 12: Global Onychomycosis Treatment Market - By Geography
Figure 13: Global Onychomycosis Treatment Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 14: Global Onychomycosis Treatment Market CAGR, By Geography, 2021-2026 (%)
Figure 15: North America Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 16: US Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 17: US GDP and Population, 2018-2019 ($)
Figure 18: US GDP – Composition of 2018, By Sector of Origin
Figure 19: US Export and Import Value & Volume, 2018-2019 ($)
Figure 20: Canada Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 21: Canada GDP and Population, 2018-2019 ($)
Figure 22: Canada GDP – Composition of 2018, By Sector of Origin
Figure 23: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 24: Mexico Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 25: Mexico GDP and Population, 2018-2019 ($)
Figure 26: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 27: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 28: South America Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 29: Brazil Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 30: Brazil GDP and Population, 2018-2019 ($)
Figure 31: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 32: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 33: Venezuela Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 34: Venezuela GDP and Population, 2018-2019 ($)
Figure 35: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 36: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 37: Argentina Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 38: Argentina GDP and Population, 2018-2019 ($)
Figure 39: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 40: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 41: Ecuador Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 42: Ecuador GDP and Population, 2018-2019 ($)
Figure 43: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 44: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 45: Peru Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 46: Peru GDP and Population, 2018-2019 ($)
Figure 47: Peru GDP – Composition of 2018, By Sector of Origin
Figure 48: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 49: Colombia Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 50: Colombia GDP and Population, 2018-2019 ($)
Figure 51: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 52: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 53: Costa Rica Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 54: Costa Rica GDP and Population, 2018-2019 ($)
Figure 55: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 56: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 57: Europe Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 58: U.K Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 59: U.K GDP and Population, 2018-2019 ($)
Figure 60: U.K GDP – Composition of 2018, By Sector of Origin
Figure 61: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 62: Germany Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 63: Germany GDP and Population, 2018-2019 ($)
Figure 64: Germany GDP – Composition of 2018, By Sector of Origin
Figure 65: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 66: Italy Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 67: Italy GDP and Population, 2018-2019 ($)
Figure 68: Italy GDP – Composition of 2018, By Sector of Origin
Figure 69: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 70: France Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 71: France GDP and Population, 2018-2019 ($)
Figure 72: France GDP – Composition of 2018, By Sector of Origin
Figure 73: France Export and Import Value & Volume, 2018-2019 ($)
Figure 74: Netherlands Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 75: Netherlands GDP and Population, 2018-2019 ($)
Figure 76: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 77: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 78: Belgium Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 79: Belgium GDP and Population, 2018-2019 ($)
Figure 80: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 81: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 82: Spain Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 83: Spain GDP and Population, 2018-2019 ($)
Figure 84: Spain GDP – Composition of 2018, By Sector of Origin
Figure 85: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 86: Denmark Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 87: Denmark GDP and Population, 2018-2019 ($)
Figure 88: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 89: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 90: APAC Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 91: China Onychomycosis Treatment Market Value & Volume, 2021-2026
Figure 92: China GDP and Population, 2018-2019 ($)
Figure 93: China GDP – Composition of 2018, By Sector of Origin
Figure 94: China Export and Import Value & Volume, 2018-2019 ($)Onychomycosis Treatment Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 95: Australia Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 96: Australia GDP and Population, 2018-2019 ($)
Figure 97: Australia GDP – Composition of 2018, By Sector of Origin
Figure 98: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 99: South Korea Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 100: South Korea GDP and Population, 2018-2019 ($)
Figure 101: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 102: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 103: India Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 104: India GDP and Population, 2018-2019 ($)
Figure 105: India GDP – Composition of 2018, By Sector of Origin
Figure 106: India Export and Import Value & Volume, 2018-2019 ($)
Figure 107: Taiwan Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 108: Taiwan GDP and Population, 2018-2019 ($)
Figure 109: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 110: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 111: Malaysia Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 112: Malaysia GDP and Population, 2018-2019 ($)
Figure 113: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 114: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 115: Hong Kong Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 116: Hong Kong GDP and Population, 2018-2019 ($)
Figure 117: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 118: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 119: Middle East & Africa Onychomycosis Treatment Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 120: Russia Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 121: Russia GDP and Population, 2018-2019 ($)
Figure 122: Russia GDP – Composition of 2018, By Sector of Origin
Figure 123: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 124: Israel Onychomycosis Treatment Market Value & Volume, 2021-2026 ($)
Figure 125: Israel GDP and Population, 2018-2019 ($)
Figure 126: Israel GDP – Composition of 2018, By Sector of Origin
Figure 127: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 128: Entropy Share, By Strategies, 2018-2019* (%)Onychomycosis Treatment Market
Figure 129: Developments, 2018-2019*Onychomycosis Treatment Market
Figure 130: Company 1 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 131: Company 1 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 132: Company 1 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 133: Company 2 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 134: Company 2 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 135: Company 2 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 136: Company 3Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 137: Company 3Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 138: Company 3Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 139: Company 4 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 140: Company 4 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 141: Company 4 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 142: Company 5 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 143: Company 5 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 144: Company 5 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 145: Company 6 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 146: Company 6 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 147: Company 6 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 148: Company 7 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 149: Company 7 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 150: Company 7 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 151: Company 8 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 152: Company 8 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 153: Company 8 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 154: Company 9 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 155: Company 9 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 156: Company 9 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 157: Company 10 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 158: Company 10 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 159: Company 10 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 160: Company 11 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 161: Company 11 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 162: Company 11 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 163: Company 12 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 164: Company 12 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 165: Company 12 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 166: Company 13Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 167: Company 13Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 168: Company 13Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 169: Company 14 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 170: Company 14 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 171: Company 14 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 172: Company 15 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 173: Company 15 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 174: Company 15 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)